Ibiden (4062) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
29 Oct, 2026Executive summary
Q2 FY2026 net sales rose to ¥262,546 million and operating profit to ¥60,116 million; attributable profit reached ¥38,574 million.
Full-year FY2026 forecasts were revised to net sales of ¥565,000 million and operating income of ¥133,000 million.
Financial highlights
Q2 net sales increased 34.3% YoY; operating profit rose 84.6%, ordinary profit 88.9%, and attributable profit 74.8%.
Gross profit was ¥97,705 million versus ¥67,913 million YoY; income before taxes was ¥59,358 million versus ¥31,985 million.
Adjusted for stock splits effective January 1 and October 1, basic EPS was ¥68.63 and diluted EPS ¥65.10, versus ¥39.52 and ¥37.13, respectively.
Comprehensive income was ¥41,430 million versus ¥37,612 million YoY, including ¥2,562 million of other comprehensive income.
Outlook and guidance
Revised FY2026 forecast: net sales ¥565,000 million (+35.8%), operating income ¥133,000 million (+114.4%), ordinary income ¥134,500 million (+121.1%) and attributable profit ¥89,000 million (+39.7%).
Forecast EPS is ¥157.17 after the October stock split; without considering that split, full-year EPS would be ¥314.35.
Guidance is based on available information and assumptions; actual results may differ significantly.
Latest events from Ibiden
- Strong Q1 growth and robust electronics demand drove major upward FY2026 forecast revisions.4062
Q1 2027 - Strong sales and profit growth, robust electronics, and a 2-for-1 stock split highlight outlook.4062
Q4 2026 - Strong Q3 growth, stock split, and major investment plan to boost high-performance IC substrate capacity.4062
Q3 2026 - Strong sales and profit growth, stock split, and robust outlook driven by electronics.4062
Q2 2026 - Strong first-quarter growth driven by electronics, with raised full-year outlook.4062
Q1 2026 - Operating profit rose 38% despite a 7% sales decline, with strong cash flow and stable outlook.4062
Q1 2025 - Profit growth offset lower sales, but comprehensive income dropped on market-related losses.4062
Q2 2025 - Profit rose 7% in FY2024, but FY2025 net profit is forecast to decline amid tariff risks.4062
Q4 2025 - Q3 sales and profit declined, but gross margin and capital adequacy improved.4062
Q3 2025